CROSSOVER Allround Bike Helmet Highlights
Style, comfort, and fit. You get it all with Crossover, a versatile all-around cycling helmet with a removable visor and rear LED integrated into the easy dial fit system.
HubRx has appointed Dr Sarah Passmore as superintendent pharmacist ahead of launching what the company called "the UK's first state-of-the-art automated pharmacy
hub".
Dr Passmore brings more than 20 years of pharmacy experience - having held key regulatory roles with Rowlands Pharmacy over a 11-year tenure, which also saw her
involved in a number of pharmacy automation projects.
Commenting on her appointment, Dr Passmore said: "As a pharmacist, who has spent more than 10 years working within community pharmacy, I'm excited by what a hub and
spoke model for prescription dispensing can bring.
"Pharmacists are highly trained in delivering clinical services to patients - and like me - it's often a part of their job that they thoroughly enjoy. The option of
using hub and spoke to support dispensing prescriptions will give community pharmacists the gift of more time that can be spent helping patients.
"I'm excited to join HubRx and for it to become the first state-of-the-art automated pharmacy hub designed for independent community pharmacists to launch in the UK."
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients
and consumers on a number of subjects including the use of dietary supplements. Their role in the sale of and advice regarding natural health and drug alternatives
has never been more relevant.
The recent National Health Service (NHS) Interim People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists
as a critical part of multidisciplinary teams, providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of
taking control, which the prescription process often denies them.
Historically the immense benefits provided by the NHS have instilled a general abdication of our personal health control, leaving us to rely on the health service
to treat and cure as necessary.
As our NHS has become visibly over-stretched we begin to realise what the rest of the world has known for centuries - good health is based primarily upon nutritional
robustness. It may be stating the obvious but there is an excellent source of incremental revenue for the pharmacist who is willing to provide space to and advice
for nutritional supplements.
Thanks to the NHS primary care access recovery plan, more than 23 million people can now view test results and check their consultation notes online without
needing to contact their GP practice.
NHS England on Monday (4 December) announced that over 81 GP practices in England (more than four in five) are now giving patients access to their new health
records online through the NHS App.
In May, the NHS announced the primary care access recovery plan setting a target of 9 in 10 GP practices offering patients access to their records through the
NHS App by March 2024.
By making access to healthcare easier and quicker, the NHSE also aims to free up to 10 million GP appointments a year by next winter.
Community pharmacists are readily accessible healthcare providers and medicine experts in the community setting and their counsel is often sought by patients and consumers on a number of subjects including the use of dietary supplements.
Their role in the sale of and advice regarding natural health and drug alternatives has never been more relevant. The recent National Health Service (NHS) Interim
People Plan calls for the NHS to put all staff front and centre of the way it operates and identifies pharmacists as a critical part of multidisciplinary teams,
providing care across a wide range of increasingly complex patient needs.
Despite existing demand to counsel patients on a vast range of medicines, more and more consumers are looking to their pharmacist to support and enhance their
knowledge regarding the relevance of a growing range of supplementary nutrients now available.
Nutritional supplementation is increasingly becoming the consumer's first choice for 'drug free' treatment or natural prevention that provides a true sense of taking control, which the prescription process often denies them.
The vast and growing depository of information on the internet is certainly fuelling this, but as much of this is brand derived content, information, it can often be generic with a 'one size fits all' marketing message.
Titan PMR has been accredited by the NHS to provide electronic prescription services (EPS) to dispensing doctors.
Over 1,000 of these doctors, who provide a vital service to almost 10 million people in rural communities, can now offer their patients the same level of benefits
and efficiencies that electronic prescriptions and Titan PMR have brought to pharmacies around the UK.
These features will also increase efficiency for dispensing doctors, who will reduce dispensing errors and improve organisation, increasing their capacity while
enjoying the ability to integrate with other technologies.
After a full year of testing, including six months of compliance testing at a practice in Cumbria, the new accreditation for Titan also has potential to help the
NHS fulfil its target of all prescriptions being issued electronically.
Currently written paper prescriptions from dispensing doctors account for around seven per cent of the total prescriptions in England - around 6.5 million each month.
"Until now dispensing doctor surgeries have basically been in the digital dark ages when it comes to dispensing medicines," said Tariq Muhammad, a tech entrepreneur
and CEO of Bristol-based Invatech Health, which developed Titan PMR.
With the chilly weather firmly settled in, it's that time of year again - cold and flu season. While there's no foolproof track to avoid getting ill, you can opt for many kinds of immunity-boosting shifts to sustain your immune system and support yourself in feeling your best!
Without further bothering, here are our top 5 pieces of advice for amplifying your immunity:
FreeStyle Libre 3 Sensors and Budesonide 500microgram orodispersible tablets sugar free have been included in the Drugs for which Discount is Not
Deducted (DND) list (Part II of the Drug Tariff) from January 2024, according to Community Pharmacy England (CPE).
Following applications made by CPE on behalf of pharmacy contractors, the Department of Health and Social Care (DHSC) agreed to give DND status to these
products to ensure that "pharmacies are not faced with dispensing these sensors at a loss."
Updated monthly by the DHSC, Part II of the Drug Tariff includes grouped and individual items.
Recently launched by Abbott Diabetes Care Ltd, FreeStyle Libre 3 Sensors have also been added to the Appliances section in Part IXA of the January 2024 Drug Tariff.
As the sensors can only be ordered by pharmacies directly from the manufacturer without any discount, CPE requested the DHSC to exempt this appliance from any
discount deduction.
What is Red Boost?
Red Boost the Most Potent, Fast-Acting Formula for Boosting Male Sexual Performance. It helps to healthy blood flow support, enhanced smooth muscle function, emotional, long- lasting performances in the bedroom and strong sexual desire all while boosting natural reserves of energy and sex drive all day long
Key Feature of Red Boost reviews
Boosting Male Sexual Performance
Healthy blood flow support
Enhanced smooth muscle function
Increased Sex Drive
Further Energy and Vitality
Easier Weight Loss and lower jones
A Sharper and Healthier Recall
Increased Performances and Youthful Stamina for your Love Life
Support Healthy Blood Pressure
Support Healthy Blood Sugar
Supporting a Healthy Immune System
The Department of Health and Social Care (DHSC) will introduce new arrangements for the setting of Drug Tariff Category A reimbursement prices from April 2024.
Driven by ministers, DHSC's decision aims to equalise access to margin on Category A medicines and it's part of a series of drug reimbursement reforms proposed by
the department following a public consultation in 2019.
Currently, prices of medicines in Category A are subject to monthly adjustment. From 1 April 2024, these will be updated quarterly based on sales and volume data
obtained by DHSC under the Health Service Products (Provision and Disclosure of Information) Regulations 2018. The transition will conclude in July 2025 when the reimbursement prices will be exclusively determined by the new method.
Advance notice for contractors regarding the 'new arrangements' has been outlined on the NHSBSA website.
However, Community Pharmacy England (CPE) did not support the introduction of the changes at this time as pharmacies are currently grappling with "wider challenges"
and there is uncertainty about the potential impact of these changes on the already "turbulent" medicines supply chain
All 42 integrated care boards (ICBs) in England have signed memorandums of understanding for the NHS Independent Prescribing Pathfinder programme, the
first nationally-funded prescribing service in the country.
Anne Joshua, interim deputy director of pharmacy commissioning at NHS England, made the revelation during the 'Chief pharmaceutical officer bi-monthly
webinar' held on 7 March 2024, as reported by The Pharmaceutical Journal.
In the initial phase of the programme, 210 community pharmacies across all ICBs will trial independent prescribing, ahead of establishing a commissioning
framework for the service.
Giving an update on the pathfinder programme, Joshua confirmed that 164 of these potential pathfinder sites had registered for the programme as of 29 February 2024.
Additionally, she announced the clinical models to be followed by the participating pharmacies and presented a graph showing an overview of the services they will
provide.